AmCham Taiwan’s 2021 Healthcare Innovation Forum was held on October 25 at the Shangri-La’s Far Eastern Plaza Hotel, drawing an audience of 80 members and their guests. The Chamber was honored to gather industry leaders and experts in tech, innovation, and healthcare fields to explore the possibilities afforded by smart healthcare. Opening remarks at the…
BoonHuey Ee, general manager of Merck Healthcare Taiwan, Hong Kong, and Macau, is a Merck veteran with more than two decades’ experience in the healthcare industry. Ee has acquired in-depth knowledge of local and regional markets and had extensive exposure to various complex healthcare environments from her various managerial roles across the Asia-Pacific region. As…
While Taiwan has seen a surge in the adoption of telemedicine in recent months, its utilization rate of home-based dialysis is less than half that of the Asia Pacific average. The COVID-19 pandemic has accelerated the digitalization of healthcare and increased the market for telemedicine. As a result of capacity-saving efforts and swift innovation during…
In the newly released 2020 Global Women’s Health Index, Taiwan scores highly in general healthcare and fertility treatment, much remains to be done to improve preventive care. On September 21, multinational women’s health company Hologic Inc., released the 2020 Hologic Global Women’s Health Index, as part of the Gallup World Poll. The survey includes data…
Despite being held virtually this year due to COVID-19 restrictions, BIO Asia-Taiwan 2021 gave attendees the chance to enjoy a broad range of presentations, panel discussions, and business networking opportunities from the comfort of their homes. For the first time in its history, BIO Asia-Taiwan went completely online this year. The event, which took place…
The COVID-19 pandemic has presented Taiwan with a unique opportunity to gain a lead in the Asia-Pacific’s new drug discovery sector. But for Taiwan to excel, the biomedical industry is calling for a change of policies. Taiwan has been striving for many years to position itself as a regional biomedical hub and an attractive location…
Healthcare providers globally have faced unprecedented workloads since the outbreak of COVID-19 last year. The pandemic response has additionally altered how, where, and when care is provided, revealing the need for fundamental changes across care-related industries. To address these and other challenges, Microsoft, which has long been at the forefront of the big-tech push into…
Despite rigorous border control and strict measures, COVID-19 has made its way into Taiwan. Now businesses, researchers, and government are working on innovations that will put Taiwan back in business. Until recently, Taiwan had a remarkable success record in containing the spread of COVID-19 and maintaining normality for its citizens. While hospitals worldwide had their…
Research-based biopharmaceutical multinational AstraZeneca, one of the earliest healthcare companies to enter the Taiwan market, has been working to deliver the best in patient care in Taiwan for over 70 years. The company’s dedication to advancing medical science is reflected in its innovation and outstanding performance in R&D. It is also focused on “beyond the…
Although a newcomer to the healthcare scene, global pharmaceutical company Viatris, formed in November 2020 through a merger of Upjohn, a legacy division of Pfizer, and Mylan, already has a sizable industry footprint. By combining the two complementary businesses, the merger has accelerated their ability to serve patients and expanded their resources across more than…
